Area of research
Oncology · Cancer Research
Research interest
Research focused on Matrix metalloproteinase and Peptide, with related work in Triple-negative breast cancer, Proteases, Protease. Notable publications include 'Mirror‐Image Random Nonstandard Peptides Integrated Discovery (MI‐RaPID) Technology Yields Highly Stable and Selective Macrocyclic Peptide Inhibitors for Matrix Metallopeptidase 7', 'Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells', and 'Engineered protein inhibitors for precise targeting of matrix metalloproteinases'.
Engineered protein inhibitors for precise targeting of matrix metalloproteinases
Mirror‐Image Random Nonstandard Peptides Integrated Discovery (MI‐RaPID) Technology Yields Highly Stable and Selective Macrocyclic Peptide Inhibitors for Matrix Metallopeptidase 7
Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension